Viemed Raises 2026 Revenue Guidance Floor
Viemed reported Q3 revenue of $80.7 million with double-digit year-over-year growth. It raised the low end of full-year revenue guidance, narrowed its Adjusted EBITDA range and lowered its net capital expenditure outlook; guidance excludes potential future acquisitions.
Story updates
10:33:20 PM UTC
SquawkNews
Viemed Healthcare, Inc. announced its financial results for the third quarter ended September 30, 2026, achieving record net revenue of $80.7 million, a 12.2% increase compared to the same period in 2025. Net income for the quarter was $4.6 million, or $0.11 per diluted share, up from $3.5 million, or $0.09 per diluted share, in the prior-year quarter. Adjusted EBITDA reached $17.1 million, reflecting a 5.8% year-over-year increase and a 24.4% sequential improvement. The company also reported growth in key operational metrics, including a 7.4% year-over-year increase in ventilator rental revenue and a 37.5% increase in PAP therapy patients. Management also provided an update to the company's guidance for the full year ending December 31, 2026.